We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Ultrasonographic Bladder Wall Thickness and Different Forms of Detrusor Overactivity

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01003457
Recruitment Status : Completed
First Posted : October 28, 2009
Last Update Posted : October 28, 2009
Information provided by:

Study Description
Brief Summary:

In the last decade, several authors proposed ultrasound measurement of Bladder wall thickness (BWT) for the screening of the voiding dysfunction and of the detrusor overactivity (DO). The aims of the investigator prospective study were:

  • to compare the ultrasonographic measurement of BWT in women with DO vs women with other urodynamic diagnosis in a very large population.
  • to verify whether the BWT in women with DO can be different in the clinically or urodinamically different forms of DO.

Condition or disease Intervention/treatment
Detrusor Overactivity Other: ultrasonography

Study Design

Study Type : Observational
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Ultrasonographic Bladder Wall Thickness and Different Forms of Detrusor Overactivity
Study Start Date : January 2005
Primary Completion Date : December 2008
Study Completion Date : December 2008

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Ultrasound
U.S. FDA Resources

Groups and Cohorts

Group/Cohort Intervention/treatment
detrusor overactivity Other: ultrasonography
transvaginal ultrasonography of bladder wall thickness

Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
all women with urinary dysfunction

Inclusion Criteria:

  • All women referred to our Urogynecology Unit from January 2005 to December 2008 for symptoms of OAB, stress urinary incontinence or mixed incontinence and sottoposte a prove urodinamiche complete were included in this prospective study

Exclusion Criteria:

  • The investigators excluded women with documented recurrent urinary tract infections
  • Previous antimuscarinic treatment
  • Previous pelvic surgery
  • Neurological disease
  • Vaginal prolapse > I stage
  • Symptoms or clinical and/or urodynamic signs of voiding dysfunction
  • Patients included in other ongoing clinical trials during the same study period.
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01003457

University of Insubria
Varese, Italy, 21100
Sponsors and Collaborators
Università degli Studi dell'Insubria
More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT01003457     History of Changes
Other Study ID Numbers: uninsubria1
First Posted: October 28, 2009    Key Record Dates
Last Update Posted: October 28, 2009
Last Verified: October 2009